Gates Foundation Strategic Investment Fund Logo
Share this page:


Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.

More on the types of investments we make.

Here you can explore our current and past investments, filtered by issue area or investment type.

ClinVet Logo


ClinVet specializes in conducting clinical trials to understand and improve veterinary health products. With the help of the foundation, ClinVet was able to construct a new facility in Morocco to expand its capabilities to conduct trials for livestock products.

CropIn Technology

CropIn is a Bangalore-based company developing software-as-a-service for agriculture enterprises to drive efficiency in farming operations. The primary use-case is for agriculture businesses (food processors, contract farming companies) whose field agents use CropIn’s SmartFarm mobile app to periodically track farm Read More

Press Release
News Story
CureVac Logo


The foundation invested in CureVac to accelerate vaccine technology development, getting life-saving and low-cost vaccines to people who need them most.

Press Release
News Story
DKT Logo


Many people across the world lack access to safe and affordable contraceptives. To address this need, we provided a low-interest loan to help DKT International increase sustainable access to vital reproductive health products in developing countries.

Press Release

Dr. Reddy’s molnupiravir

The foundation provided support to Dr. Reddy’s Laboratories, a multinational pharmaceutical company, to expand access to generic molnupiravir in low- and middle-income countries.   Investment Date: March 2022

Eastside Preparatory School

Eastside Preparatory School is a college-preparatory school located in Kirkland, Washington. The foundation provided a loan to support an expansion of the organization’s campus. Investment Date: February 2017

Enko Chem

Enko Chem is an early stage agricultural life sciences company that is looking to apply DNA encoded library technology to identify and develop new, safer chemical compounds that protect crops from pests and disease. The foundation invested in the Company Read More

Press Release

Evolve BioSystems

Evolve BioSystems is an infant microbiome company dedicated to developing the next generation of products to establish, restore and maintain a healthy gut microbiome. The foundation is working with Evolve to further develop and apply its lead probiotic, Evivo, to Read More

Press Release
News Story

Exscientia AI Limited

Exscientia plc is an artificial intelligence-driven pharmaceutical company focused on discovering, designing, and developing drugs in a fast, efficient manner, with three AI-designed drugs that are in Phase 1 human clinical trials. The foundation invested in the Company to develop Read More

Press Release

Gavi / Serum

The foundation has partnered with Gavi and the Serum Institute of India (“SII”) to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for low- and middle-income countries. The collaboration was expanded in August 2020 Read More

Press Release
Genocea Logo


Genocea harnesses the power of T cells to discover life-changing vaccines and immunotherapies. The foundation partnered with the team to identify antigens for future malaria vaccines as T cell response is critical during the liver-stage of disease.

Press Release
Case Study

Global Health Investment Fund (GHIF)

The foundation sponsored the creation of GHIF as a social impact investment fund to support the development of drugs, vaccines, and diagnostics for diseases that specifically burden low- and middle-income populations.

Press Release

Growth Markets Health Fund

The Abraaj Growth Markets Health Fund is an investment fund designed to address poor health outcomes caused by inefficient healthcare systems in Africa and Asia.


Halodoc is an online-to-offline (“O2O”) health delivery marketplace launched in 2016 and based in Jakarta, Indonesia. The Company aims to improve accessibility, affordability, and quality of healthcare for at least 100 million Indonesians by systemically addressing inefficiencies and resource misallocation Read More

Press Release
News Story

Hester Biosciences Africa Limited

Hester Biosciences Africa Limited (“Hester Africa”), a newly-formed Tanzanian company and a wholly-owned subsidiary of Hester Biosciences Limited (“Hester”), is building an animal vaccine manufacturing facility near Dar es Salaam. Hester has a 20-year track record manufacturing and distributing livestock Read More

immunocore logo


Immunocore develops innovative biological therapeutics that exploit the power of the body’s own immune system to find and kill diseased cells. The foundation partnered with the company to expand its focus into infectious disease.

Press Release
Intarcia Logo


The foundation invested in Intarcia to help prevent the spread of HIV in Sub-Saharan Africa and other areas where the HIV epidemic is most severe.

Press Release
News Story

Inventprise LLC

Inventprise is an innovative vaccine development company based out of Redmond, Washington that is focused on developing efficacious, affordable vaccines for global populations most in need. The foundation invested in the Company to advance its novel pneumococcal conjugate vaccine (“IVT-25”). Read More

Press Release

Just Biotherapeutics

Just Biotherapeutics is developing an integrated technology platform to accelerate the development and manufacturing of high-quality biologics at a significantly lower cost, to broaden global biologic access.


KIPP Houston

KIPP Houston is a Charter Management Organization (CMO) and a top-ranked school system for low-income students. The investment provided affordable facility financing to high-performing CMOs.

Press Release
kymab logo


Kymab has developed a proprietary mouse platform which contains the full range of human antibodies, leading to faster discovery of prophylactic and therapeutic monoclonal antibodies.

Press Release
Case Study

Lilly mAb

The foundation partnered with Eli Lilly and Company to facilitate access to future Lilly therapeutic antibodies under development for the prevention and treatment of COVID-19 for low- and middle-income countries as part of the COVID-19 Therapeutics Accelerator. The COVID-19 antibodies Read More

Press Release
Liquidia Logo


The foundation invested in Liquidia to support the application of Liquidia’s PRINT® technology to vaccine development for infectious diseases.

Lodo Therapeutics Logo

Lodo Therapeutics

Lodo Therapeutics is creating a best-in-class natural product drug discovery platform for the discovery, biosynthesis, and characterization of new, genetically encoded small molecules.


LumiraDx develops point-of-care diagnostics solutions on a portable, cloud-connected reader using finger-prick blood samples tested on disposable, microfluidic strips. The company is working to achieve lab-quality performance and health-IT integration at point-of–care settings globally. The foundation invested in the company Read More

Lyndra Therapeutics

Lyndra Therapeutics is developing an orally administered dosage form designed to deliver sustained, steady-state release of one or more drugs for up to a week or longer while temporarily residing in the stomach. The foundation invested in the company to Read More

Press Release
M-Kopa Logo


M-KOPA is a Nairobi-based, off-grid solar energy company, which makes residential power systems affordable and accessible to low-income, off-grid customers through a mobile payment-based lease-to-own model.

Press Release
Case Study
Medical Credit Fund Logo

Medical Credit Fund (MCF)

The Medical Credit Fund provides loans and technical assistance to small primary care clinics in Africa. Through the loan fund, MCF expanded its lending and technical assistance across Ghana, Nigeria, Kenya, and Tanzania.

Press Release
Merck Logo


The foundation partnered with private and public organizations make Implanon NXT®, a single rod, long-acting, reversible contraceptive implant, available in the world’s poorest countries at a more than 50 percent price reduction.

Press Release
Case Study
Mylan Logo

Mylan Dolutegravir

Mylan Laboratories, along with Aurobindo Pharma, received support from the foundation to expand the distribution of a single-pill HIV treatment containing dolutegravir to low- and middle-income populations at a low price.

Press Release
News Story